Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-06
1996-11-12
Fan, Jane
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514318, 514337, 514218, 514339, 514309, 546256, 546194, 5462784, 546141, 546257, 5462771, 546 13, 5462827, 5462831, 540524, A61K 3144, C07D40714
Patent
active
055740499
ABSTRACT:
2,2-di(C.sub.1-5 alkyl)- and trans-2,2-di(C.sub.1-5 alkyl)-3,4-dihydro-3-hydroxy-6-(pyridin-4-yl)-2H-1-benzopyrans, e.g. of formula ##STR1## in which R.sub.1 and R.sub.2 =H, alkyl, hydroxyalkyl or alkoxyalkyl, at least one being other than H, R.sub.3 =typically a 2-piperidinone group, R.sub.4 =H and R.sub.5 =--OH or R.sub.4 +R.sub.5 =an additional bond, and R.sub.6, R.sub.7 are alkyl and R.sub.8 is H or alkyl, and N-oxides, esters and salts thereof, processes for their production and their uses as pharmaceuticals e.g. as K.sup.+ -channel openers, bronchodilators and asthma prophylactic agents.
REFERENCES:
J. Med. Chem., vol. 33, No. 2, pp. 492-504 (1990).
Borovian Joseph J.
Fan Jane
Honor Robert S.
Kassenoff Melvyn M.
Sandoz Ltd.
LandOfFree
2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-562877